top of page

What Is Fibrin? Built Daily, Cleared Daily

Writer: Megan Elliott
Megan Elliott
Oct 5
10 min read

What is fibrin? It is the protein your blood turns into a mesh the moment you bleed — and the protein your body takes apart again once the repair is done. Most explainers stop at the first half. The second half is the interesting one, because it never stops: healthy adults carry low, measurable levels of fibrin breakdown products in their blood at all times, which means fibrin is being built and cleared continuously, in the background, every day of your life. That two-way traffic is what "fibrin metabolism" means when you read it on a label. It is also the phrase behind one of the claims on our own bottle — a nattokinase supplement such as Great Billiom Nattokinase 10,800 FU is positioned to support healthy fibrin metabolism — so it is worth knowing what the protein actually is before you decide what that line means to you.



Fibrin: built daily, cleared daily. Build: the liver makes fibrinogen (200–400 mg/dL); thrombin switches it to fibrin at a wound; fibrin stops bleeding, seals the wound, signals clean-up and scaffolds new vessels. Clear: plasmin cuts fibrin, switched on by tPA and uPA; PAI-1, PAI-2 and α2-antiplasmin are the brakes; D-dimer and FDPs are the leftovers. Healthy individuals have low levels of circulating D-dimer (Weitz 2017), so fibrin is built and cleared continuously — that turnover is what healthy fibrin metabolism means
Fibrin in one picture: fibrinogen from the liver, thrombin's switch, the four jobs fibrin does, the enzymes that clear it, and why healthy people always carry a little D-dimer.

Fibrin starts out as fibrinogen


Fibrin does not float around your bloodstream waiting for a cut. What circulates is its precursor, fibrinogen. Cleveland Clinic describes the hand-off in three sentences: "Fibrin comes from fibrinogen, a blood protein. Your liver makes fibrinogen, and it flows in your blood plasma. When bleeding occurs, an enzyme called thrombin triggers fibrinogen to turn into fibrin."


UCSF Health gives the typical blood level as 200 to 400 mg/dL — 2 to 4 grams per liter — making fibrinogen one of the most abundant proteins in plasma. It is soluble and inert until thrombin trims it. At that point the trimmed molecules snap together end to end and side to side, and a liquid protein becomes a solid, sticky net within seconds. That is the whole design: the body keeps the raw material in solution and ready, and converts only as much as the injury needs.


What fibrin actually does


Cleveland Clinic lists four jobs, and only the first is the one most people know. Fibrin stops bleeding by forming "a mesh to create a stable clot" — the net that traps platelets and red cells at the site of a wound. Second, it seals the injury, which keeps microbes out while the tissue underneath repairs. Third, it helps trigger the inflammatory response that begins the clean-up. And fourth, it acts as "the foundation for new blood vessels to grow." In other words, fibrin is a temporary scaffold: it closes the breach, holds the site together, and then gives the repair crew something to build on.


Every one of those jobs is temporary by design. A scaffold that stayed up forever would be a problem, not a solution — which brings us to the half of the story that explains the word "metabolism."


The other half: how the body takes fibrin apart


Once the vessel has healed, Cleveland Clinic says, "your body breaks down fibrin. It turns into substances called fibrin degradation products (FDPs)." The system that does this is called fibrinolysis, and a 2015 review in Blood Reviews by Chapin and Hajjar lays out the cast.


The cutting enzyme is plasmin. "Plasmin is the primary fibrinolysin, and is activated from plasminogen by either of two primary serine proteases, tPA and uPA." Plasminogen is the inactive form that circulates in your blood; tissue plasminogen activator (tPA) and urokinase (uPA) switch it on, and they come from different places: "Whereas tPA is synthesized and released by endothelial cells, uPA is produced by monocytes, macrophages, and urinary epithelium." The endothelial cells are the lining of your blood vessels — so the vessel wall itself releases the activator that starts clearing fibrin from its own surface.


Then there are the brakes. "The three serpins most important in fibrinolysis are plasminogen activator inhibitor-1 (PAI-1), plasminogen activator inhibitor-2 (PAI-2), and α2-antiplasmin." PAI-1 holds back the activators; α2-antiplasmin mops up free plasmin so it only works where fibrin is. And the whole thing is wired to the clotting side: "The coagulation and fibrinolytic systems are highly regulated and inter-related through mechanisms that insure balanced hemostasis." Building and clearing are not two separate programs. They are one system with an accelerator and a brake, tuned so that fibrin forms where it is needed and comes down when it is not.


The player

Made where

What it does

Source

Fibrinogen

Liver

Circulates at 200–400 mg/dL; the raw material for fibrin

Cleveland Clinic; UCSF Health

Thrombin

Clotting cascade

Converts fibrinogen into fibrin at the site of a wound

Cleveland Clinic

Fibrin

Built on site

Forms the mesh, seals the wound, signals inflammation, scaffolds new vessels

Cleveland Clinic

Plasminogen → plasmin

Circulates inactive; activated on fibrin

The enzyme that cuts fibrin into degradation products

Chapin & Hajjar 2015

tPA and uPA

Vessel lining (tPA); monocytes, macrophages (uPA)

Switch plasminogen on

Chapin & Hajjar 2015

PAI-1, PAI-2, α2-antiplasmin

Various

The brakes that keep fibrinolysis local and measured

Chapin & Hajjar 2015

D-dimer and FDPs

Released as fibrin is cut

The leftovers that show fibrin was built and then cleared

Chapin & Hajjar 2015; Weitz 2017


Built daily, cleared daily: what D-dimer tells you


Here is the evidence that fibrin turnover is a daily event and not an emergency-only one. When plasmin cuts cross-linked fibrin, one of the fragments it releases is D-dimer. Chapin and Hajjar put it technically: "When fibrin polymers are cleaved by plasmin at the D fragment site, the resulting D-dimer fragment reflects the degree of thrombosis and plasmin activity." A 2017 review in the Journal of the American College of Cardiology calls D-dimer "a global marker of activation of the coagulation and fibrinolytic systems" — and then states the fact this article is built on: "Healthy individuals have low levels of circulating D-dimer."


D-dimer only exists if fibrin was first formed and then cut by plasmin. If healthy people always have some, then healthy people are always making a little fibrin and always clearing it. A 2003 study in the Journal of Thrombosis and Haemostasis measured exactly this in 466 healthy adults, describing D-dimer as "a fibrin degradation product that indicates activation of both the coagulation and the fibrinolytic system," and found its level tracked with fibrinogen and several clotting factors — a picture of one connected system idling, not a system switched off. That reading is ours, but it rests on both papers' own words: in health, fibrin is built daily and cleared daily, at low volume, with the brakes on.


This is the part most "what is fibrin" explainers leave out. Fibrin metabolism is not a once-a-year event when you scrape a knee. It is a continuous, regulated turnover — the same way bone is constantly built and resorbed, or the way your liver makes and clears cholesterol — and "healthy fibrin metabolism" simply means that turnover running normally.


Fibrin, fibrinogen, fibrinolysis: the vocabulary in one place


Three words that look alike and get swapped constantly:


  • Fibrinogen is the soluble precursor the liver makes. It is what a fibrinogen blood test measures.

  • Fibrin is the insoluble mesh that fibrinogen becomes when thrombin acts on it. It exists only at a repair site.

  • Fibrinolysis is the breakdown of fibrin by plasmin. Its leftovers are the fibrin degradation products, including D-dimer.


A fibrinolytic enzyme, then, is any enzyme that cuts fibrin. Plasmin is your own. Nattokinase is one from food.


What "healthy fibrin metabolism" means on a supplement label


Nattokinase is the enzyme that gives natto — the fermented soybean dish eaten in Japan for centuries — its fibrin-cutting activity, and it is measured in FU, fibrinolytic units, which the Japan NattoKinase Association defines as "the unit that indicates the activity of nattokinase." If the unit is new to you, our guide to what 10,800 FU means on a nattokinase label explains why an enzyme is measured by activity rather than milligrams, and our piece on natto vs nattokinase covers how much of the enzyme a bowl of the food delivers.


How does it relate to the system above? A 2017 review in the International Journal of Molecular Sciences describes nattokinase as a 275-amino-acid enzyme of 27.7 kDa that acts on several points of the fibrinolytic cascade at once: it directly hydrolyzes fibrin, converts endogenous prourokinase to urokinase (uPA), degrades PAI-1, and increases tissue plasminogen activator (tPA). Read against the cast list earlier, that is the accelerator side of the system, plus one of the brakes. The same review notes that "a research team in the United States detected intact NK in the serum of healthy humans after they were administrated a single, oral dose," which answers the obvious objection that an enzyme would simply be digested.


The human-marker evidence is modest and worth stating precisely. In a 2015 study in Scientific Reports, 12 healthy young men took a single 2,000 FU dose. Over the following hours, fibrin/fibrinogen degradation products rose 21.2 percent at the four-hour mark and D-dimer rose 44.5 percent and 38.2 percent at six and eight hours — the same fibrin-breakdown markers discussed above — and enzyme activity was detectable in serum from two to 24 hours after the dose. The authors' own summary of every change: "All the changes, however, were within the normal range." That is the structure/function territory in one sentence. Twelve men, one dose, blood markers rather than outcomes, and a system that stayed inside its normal operating band. It is evidence that nattokinase engages the body's fibrin-clearing machinery; it is not evidence about any disease, and no one should read it that way.


Where Great Billiom Nattokinase 10,800 FU fits


Great Billiom Nattokinase 10,800 FU with K2 MK-7 and serrapeptase, seen from above among dry soybeans, a glass of water and a notebook — supports healthy fibrin metabolism and healthy blood flow and circulation*
Great Billiom Nattokinase 10,800 FU with K2 MK-7 and serrapeptase beside a bowl of natto — supports healthy fibrin metabolism and healthy blood flow and circulation.*

Everything above is about a system your body already runs. A nattokinase supplement is daily support for that system, not a replacement for it. In structure/function terms, Great Billiom Nattokinase 10,800 FU supports healthy fibrin metabolism and blood viscosity, healthy blood flow and circulation, and cardiovascular wellness as part of an active lifestyle for adults 40 and over — the same positioning you will find on our product page, where the formula is described as supporting your body's natural ability to maintain healthy blood flow, blood viscosity and daily circulation. If a long desk day is the reason you are reading, our review of what 24 trials show about circulation while sitting covers the movement side, and nattokinase sits alongside those breaks, never instead of them.


Each two-capsule serving delivers 10,800 FU of nattokinase — matching the higher dose arm of the largest nattokinase study to date, 1,062 adults followed for 12 months in Frontiers in Cardiovascular Medicine, whose authors state plainly that it "represents a retrospective study and not a randomized control trial" — together with 180 mcg of vitamin K2 as MK-7, which supports calcium delivery to bones and teeth, and 240,000 SPU of serrapeptase, a second proteolytic enzyme. The capsules are delayed-release and vegetarian: 90 per bottle, 45 servings, $19.99, or $17.99 on Subscribe & Save. The label directs two capsules daily on an empty stomach, at least an hour before or two hours after a meal. Nattokinase contains soy. Because it engages the fibrin-clearing system described in this article, anyone taking an anticoagulant, antiplatelet or blood-pressure medication, anyone pregnant or nursing, and anyone with surgery scheduled should talk to their doctor before starting it — the product page says the same, and it is not a substitute for any prescription. The formula's third ingredient, serrapeptase, is a second protein-cutting enzyme from a different family; our explainer on what serrapeptase is covers where it comes from and what its trials did and did not show.



Key takeaways


  • Fibrin is the protein mesh your body builds from fibrinogen — made in the liver, circulating at 200–400 mg/dL — when thrombin signals an injury (Cleveland Clinic; UCSF Health).

  • It does four jobs: stops bleeding, seals the wound, triggers the inflammatory clean-up and scaffolds new vessels — all temporary by design (Cleveland Clinic).

  • The body takes fibrin apart with plasmin, switched on by tPA from the vessel lining and uPA, and held in check by PAI-1 and α2-antiplasmin; the two systems are "inter-related through mechanisms that insure balanced hemostasis" (Chapin & Hajjar 2015).

  • "Healthy individuals have low levels of circulating D-dimer" — the fragment that only exists after fibrin is built and then cut — so in health, fibrin turnover is continuous, not emergency-only (Weitz 2017; van Hylckama Vlieg 2003, n=466).

  • Nattokinase directly hydrolyzes fibrin and raises the body's own activators; in 12 healthy men a single 2,000 FU dose moved fibrin-breakdown markers while "all the changes … were within the normal range" (Weng 2017; Kurosawa 2015).


Fibrin is not a villain and it is not a one-time event. It is a protein your body builds and clears every day, in balance, with its own accelerator and brake. If you want daily support for that balance — healthy fibrin metabolism, healthy blood flow and circulation — Great Billiom Nattokinase 10,800 FU gives you the research-matched dose with K2 MK-7 and serrapeptase in one two-capsule serving, for $19.99.



Frequently asked questions


What is fibrin in simple terms?


Fibrin is a sticky protein mesh your body builds in seconds to stop bleeding and seal a wound. It is made from fibrinogen, a protein your liver produces and keeps in your blood, which the enzyme thrombin converts into fibrin at an injury. Once the repair is done, your body breaks the fibrin down again.


Is fibrin the same as fibrinogen?


No. Fibrinogen is the soluble precursor that circulates in plasma at about 200 to 400 mg/dL; fibrin is the insoluble mesh it becomes when thrombin acts on it. A fibrinogen blood test measures the precursor, not fibrin itself. Think of fibrinogen as the raw material kept in stock and fibrin as the structure built from it when needed.


What breaks down fibrin in the body?


An enzyme called plasmin, which circulates as inactive plasminogen until tPA from the vessel lining or urokinase switches it on. Inhibitors such as PAI-1 and α2-antiplasmin keep the process local and measured. The fragments left over, including D-dimer, show that fibrin was built and then cleared, and healthy people carry low levels of them all the time.


What does "supports healthy fibrin metabolism" mean on a supplement label?


It is a structure/function claim about the body's normal, continuous turnover of fibrin — building it where needed and clearing it afterward. It is not a claim about any disease. For a nattokinase product it refers to the enzyme's fibrin-cutting activity, measured in FU, and the research in healthy adults showing fibrin-breakdown markers moving within the normal range.


Does nattokinase act on fibrin?


Yes, in the research so far. A 2017 review describes nattokinase as directly hydrolyzing fibrin and raising the body's own activators, and a 2015 study in 12 healthy men found fibrin-breakdown markers rose after one 2,000 FU dose while staying within the normal range. Those are enzyme-level findings, not disease outcomes. If you take any medication, ask your doctor first.


Megan Elliott, Content Editor at Great Billiom. Every claim in this article is sourced from the primary research linked above. Read our editorial standards → thegreatbilliom.com/editorial-standards


Sources



These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.


Comments

bottom of page